Tag: Over-the-Counter Drugs and Devices

Displaying 21 - 37 of 37 results.

Two marketers of unproven cedar oil-based remedies for bed bugs and head lice have agreed to enter into settlements with the Federal Trade Commission that prohibit the allegedly deceptive claims, and require pre-approval from the Food and Drug Administration for any future treatment claims about...
The Federal Trade Commission has mailed 10,144 checks to consumers who bought Disney- or Marvel Hero-themed vitamins for their kids that featured characters such as the Disney Princesses, Winnie the Pooh, Finding Nemo, and Spider-Man.
At the request of the Federal Trade Commission and the states of Illinois, Kentucky, and North Carolina, a federal court has halted an allegedly illegal pyramid scheme pending trial.  The FTC and the state attorneys general seek to stop the allegedly illegal practices of the Fortune Hi-Tech...
The Federal Trade Commission announced that an operation that marketed acai berry supplements, "colon cleansers," and other products using allegedly fraudulent free trial offers and phony endorsements from Oprah Winfrey and Rachael Ray will pay $1.5 million as part of a settlement. The money will...
At the request of the Federal Trade Commission, a U.S. district court has ordered the marketers of acai berry supplements, “colon cleansers,” and other products to temporarily halt an Internet sales scheme that allegedly scammed consumers out of $30 million or more in 2009 alone through deceptive...
The Federal Trade Commission has sent letters to 11 companies that promote various Omega-3 fatty acid supplements, telling them they should review their product packaging and labeling to make sure they do not violate federal law by making baseless claims about how the supplements benefit children’...
Two dietary supplement marketers that lured consumers on the Internet with allegedly deceptive weight-loss claims and bogus “free” sample offers, and then debited their bank accounts or charged their credit cards for continuing shipments without their consent, have agreed to settle Federal Trade...
In order to restore competition in the U.S. market for consumer pregnancy tests, the Commission effectively reversed a consummated transaction in which Inverness Medical Innovations, a 70% market share holder, purchased the assets related to the development of a water-soluble dye...
Commission approval of final consent order: Following a public comment period, the Commission has approved the issuance of final consent order in the matter concerning Johnson & Johnson’s acquisition of Pfizer, Inc.’s Consumer Healthcare business. The vote to approve the final consent order,...
The consent order settles charges that Johnson & Johnson’s (J&J) proposed $16.6 billion acquisition of Pfizer Inc.’s (Pfizer) Consumer Healthcare business would likely reduce competition in the U.S. markets for over-the-counter (OTC) H-2 blockers used to prevent and relieve...
The Federal Trade Commission today announced its decision to challenge the terms of Johnson & Johnson’s (J&J) proposed $16.6 billion acquisition of Pfizer Inc.’s (Pfizer) Consumer Healthcare business. The FTC’s complaint alleges that the transaction as originally proposed would reduce...
The Commission authorized staff to file a complaint in federal district court charging that Alpharma, Inc. and Perrigo Company drove up the prices for over-the-counter store-brand children’s liquid ibuprofen through an agreement eliminating competition between the two firms and...
Generic drug manufacturers Alpharma, Inc. and Perrigo Company will give up $6.25 million in illegal profits to settle Federal Trade Commission charges that their agreement to limit competition for over-the-counter (OTC) store-brand children’s liquid ibuprofen drove up prices and violated federal...
The United States Court of Appeals for the District of Columbia has unanimously upheld a Federal Trade Commission decision ordering the maker of Doan's Pills to run corrective advertising. The Court's opinion denied Novartis Corporation's appeal of the 1999 FTC order requiring it to include in...
The Federal Trade Commission has ordered the makers of Doan's Pills to run ads to correct misbeliefs resulting from their unsubstantiated claim that Doan's Pills are superior to other over-the-counter analgesics for treating back pain.
An administrative law judge has upheld Federal Trade Commission charges that ads claiming that Doan's pills are more effective in relieving back pain than other over-the-counter pain relievers are unsubstantiated and false. Judge Lewis F. Parker's order would bar Novartis Corporation and Novartis...
Final order preserves competition in the production and sale of opaque contact lenses. The order permits the acquisition of Pilkington Barnes Hind International, Inc. but requires the divestiture of the opaque contact lens business within four months to a Commission approved acquirer...

Pages